Kiran Mazumdar-Shaw, Biocon executive chair (Photo by Indranil Aditya/NurPhoto via AP)
Biocon lands FDA approval for another Stelara biosimilar
Biocon Biologics scored an FDA approval for its Stelara biosimilar, marketed as Yesintek, the company announced Monday.
Biocon entered into a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
